Drug Pricing

Business & Economics

Drug Prices That Matter

Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
Commentary

Bernie Sanders’ drug price controls would stifle medical innovation

Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
Commentary

After Midterms, Democrats Inch Toward Government-Run Health Care

The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
Business & Economics

The Bizarre World of Drug Pricing

There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Drug Pricing

Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times

‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Commentary

Putting Drug Prices on TV Will Cause Unnecessary Patient Panic

Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Business & Economics

Wayne Winegarden Talks Drug Pricing Transparency on Lars Larson Show

Listen to PRI’s senior fellow in business and economics Dr. Wayne Winegarden discuss President Trump’s drug pricing transparency proposal on the nationally-syndicated “Lars Larson Show.”  The interview begins at the 54:25 mark.
Blog

Does President Trump Favor Price Controls?

At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Commentary

Drug prices in ads actually hurt consumers

This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs covered by Medicare or Medicaid to include the list price of the medicine. To be sure, a free market is dependent on consumers making informed decisions. But this move would provide patients with incomplete, misleading numbers ...
Business & Economics

Wayne Winegarden Talks Drug Pricing Advertising on Newsmax TV

Watch PRI’s Wayne Winegarden discuss the Trump Administration proposal on drug pricing advertising on “America Talks Live” with Dr. Gina Loudon and John Cardillo on Newsmax TV.
Business & Economics

Drug Prices That Matter

Too often, drug pricing analyses do not shed light on how much drug expenditures are actually increasing because these studies examine the wrong price. The latest iteration is an analysis by Rx Savings Solutions. According to the Wall Street Journal, Rx Savings Solutions documented that dozens of drug makers raised the ...
Commentary

Bernie Sanders’ drug price controls would stifle medical innovation

Sen. Bernie Sanders, I-Vt., and Rep. Ro Khanna, D-Calif., recently proposed bills that would impose price controls on prescription drugs. The legislation would require pharmaceutical companies to sell their medicines in the United States for no more than the median price charged in five countries – Canada, the United Kingdom, France, Germany, ...
Commentary

After Midterms, Democrats Inch Toward Government-Run Health Care

The midterm elections were good to Democrats. They took the majority in the U.S. House and captured several state legislatures. Public frustration with health care was a big reason why. Just before the election, seven in 10 voters said that the issue was “very important” when deciding whom to vote ...
Business & Economics

The Bizarre World of Drug Pricing

There is no shortage of bad ideas when it comes to the pharmaceutical market. One such proposal would allow drugs to be imported directly from other countries, such as Canada. Then there is the Trump Administration’s proposal that would effectively adopt foreign price controls on Medicare Part B drugs by ...
Drug Pricing

Sally Pipes Talks ‘Reinsurance’ Obamacare Fix in Washington Times

‘Reinsurance’ Obamacare fix wins bipartisan support in Senate By Tom Howell, Jr. Sen. Joe Manchin III, a West Virginia Democrat who just won re-election in one of the country’s reddest states, has an idea to fix Obamacare — call in President Trump. The West Virginian is among senators on both ...
Commentary

Putting Drug Prices on TV Will Cause Unnecessary Patient Panic

Last month, the Trump administration proposed several reforms to drive down prescription drug prices. One measure would force pharmaceutical companies to mention the sticker prices of their medicines in television advertisements. The new mandate covers all prescriptions drugs reimbursed by Medicare or Medicaid that cost more than $35 a month. The administration hopes this ...
Business & Economics

Wayne Winegarden Talks Drug Pricing Transparency on Lars Larson Show

Listen to PRI’s senior fellow in business and economics Dr. Wayne Winegarden discuss President Trump’s drug pricing transparency proposal on the nationally-syndicated “Lars Larson Show.”  The interview begins at the 54:25 mark.
Blog

Does President Trump Favor Price Controls?

At 2 pm Eastern time today, President Trump spoke at the Department of Health and Human Services where he recommended a litany of policies that would ultimately impose price controls on the pharmaceutical market. Take his proposal to force the prices paid by Medicare for drugs administer in doctors’ offices ...
Commentary

Drug prices in ads actually hurt consumers

This month, the Trump administration proposed a new rule that would require advertisements for prescription drugs covered by Medicare or Medicaid to include the list price of the medicine. To be sure, a free market is dependent on consumers making informed decisions. But this move would provide patients with incomplete, misleading numbers ...
Business & Economics

Wayne Winegarden Talks Drug Pricing Advertising on Newsmax TV

Watch PRI’s Wayne Winegarden discuss the Trump Administration proposal on drug pricing advertising on “America Talks Live” with Dr. Gina Loudon and John Cardillo on Newsmax TV.
Scroll to Top